0

R-568 hydrochloride

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP135273744
CAS135273-74-4
Structure
MDL NumberMFCD00898949
Molecular Weight220.72
Description≥95% (HPLC)
SolubilityDMSO: 2 mg/mL, clear (warmed)
Assay≥95% (HPLC)
Colorwhite to beige
Formpowder
Size5MG, 25MG
Storage Conditions2-8°C
1

Calcimimetic Agents and Secondary Hyperparathyroidism: Rationale for Use and Results From Clinical Trials

William G Goodman

Pediatr Nephrol. 2003 Dec;18(12):1206-10.

PMID: 14586685

1

Disulfonimide-Catalyzed Asymmetric Reduction of N-Alkyl Imines

Vijay N Wakchaure, Philip S J Kaib, Markus Leutzsch, Benjamin List

Angew Chem Int Ed Engl. 2015 Sep 28;54(40):11852-6.

PMID: 26382289

1

Functional Proteins Involved in Regulation of Intracellular Ca(2+) for Drug Development: The Extracellular Calcium Receptor and an Innovative Medical Approach to Control Secondary Hyperparathyroidism by Calcimimetics

Nobuo Nagano, Edward F Nemeth

J Pharmacol Sci. 2005 Mar;97(3):355-60.

PMID: 15781990

1

Pharmacological and Clinical Properties of Calcimimetics: Calcium Receptor Activators That Afford an Innovative Approach to Controlling Hyperparathyroidism

Nobuo Nagano

Pharmacol Ther. 2006 Mar;109(3):339-65.

PMID: 16102839

1

Pharmacoperones and the Calcium Sensing Receptor: Exogenous and Endogenous Regulators

Gerda E Breitwieser

Pharmacol Res. 2014 May;83:30-7.

PMID: 24291533

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode